Ravneesh Sachdev
Private Equity Investor chez ACCELERON PHARMA INC.
Profil
Mr. Ravneesh Sachdev is a Partner at Apple Tree venture Managemnet Llc//vc and a Senior Vice President at Acceleron Pharma, Inc. He received his undergraduate degree from Claremont McKenna College, a graduate degree from Keck Graduate Institute of Applied Life Sciences and an MBA from Yale University.
Postes actifs de Ravneesh Sachdev
| Sociétés | Poste | Début |
|---|---|---|
| ACCELERON PHARMA INC. | Private Equity Investor | - |
Apple Tree venture Managemnet Llc//vc
 Apple Tree venture Managemnet Llc//vc Investment ManagersFinance Apple Tree venture Managemnet LLC (Apple Tree Partners) is a venture capital firm founded by Seth Harrison in 1999. The firm is headquartered in New York with an additional offices in London, San Francisco and Cambridge. | Private Equity Investor | - |
Formation de Ravneesh Sachdev
| Claremont McKenna College | Undergraduate Degree |
| Keck Graduate Institute of Applied Life Sciences | Graduate Degree |
| Yale University | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Apple Tree venture Managemnet Llc//vc
Apple Tree venture Managemnet Llc//vc Investment ManagersFinance Apple Tree venture Managemnet LLC (Apple Tree Partners) is a venture capital firm founded by Seth Harrison in 1999. The firm is headquartered in New York with an additional offices in London, San Francisco and Cambridge. | Finance |
Acceleron Pharma, Inc.
 Acceleron Pharma, Inc. BiotechnologyHealth Technology Acceleron Pharma, Inc. is a biopharmaceutical company, which engages in the discovery, development and commercialization of therapeutics to treat serious and rare diseases. Its product candidates include Luspatercept, designed to patients with chronic anemia associated within a wide range of blood diseases; ACE-083, designed for the treatment of focal muscle disorders; and Sotatercept, designed to treat pulmonary arterial hypertension. The company was founded by John L. Knopf and Thomas P. Maniatis on June 13, 2003 and is headquartered in Rahway, NJ. | Health Technology |
